UK launch for Alliance’s pregnancy anti-nausea and vomiting drug
Alliance Pharma has announced the launch of Xonvea in the UK to treat nausea and vomiting of pregnancy (NVP) in women who do not respond to conservative management.
Read More
Tag: Xonvea
- Lundbeck completes patient randomisation early in global MSA trial
- Incyte treatment for advanced anal cancer approved in Europe
- HUTCHMED begins global trial of novel attc therapy hmpl‑a580 in solid tumours
- Theolytics awarded €8 million Horizon Europe grant to fund ovarian cancer study
- AI system aims to uncover Alzheimer’s earlier and take on diagnostic delays
